"Antithrombin III" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.
| Descriptor ID |
D000990
|
| MeSH Number(s) |
D12.644.861.060.500 D12.776.124.790.106.125 D12.776.377.715.085.125 D12.776.872.060.500 D23.113.025
|
| Concept/Terms |
Antithrombin III- Antithrombin III
- Heparin Co-Factor I
- Heparin Co Factor I
- Serpin C1
- Heparin Cofactor I
- Cofactor I, Heparin
|
Below are MeSH descriptors whose meaning is more general than "Antithrombin III".
Below are MeSH descriptors whose meaning is more specific than "Antithrombin III".
This graph shows the total number of publications written about "Antithrombin III" by people in this website by year, and whether "Antithrombin III" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antithrombin III" by people in Profiles.
-
a-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction. Diabetes. 2017 04; 66(4):970-980.
-
Thrombin generation and cell-dependent hypercoagulability in sickle cell disease. J Thromb Haemost. 2016 10; 14(10):1941-1952.
-
Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke. PLoS One. 2015; 10(8):e0134193.
-
Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke. 2006 Jul; 37(7):1798-804.
-
Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease. Thromb Res. 2006; 117(4):439-46.
-
Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor. J Thromb Thrombolysis. 2004 Dec; 18(3):193-7.
-
Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. Transplantation. 2002 Jun 15; 73(11):1717-23.
-
Hemostatic effects of antithrombin III supplementation during cardiac surgery: results of a prospective randomized investigation. Blood Coagul Fibrinolysis. 2001 Jan; 12(1):25-31.
-
Effectiveness of heparin in preventing thrombin generation and thrombin activity in patients undergoing coronary intervention. Am Heart J. 1999 Feb; 137(2):250-7.
-
The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg. 1997 Dec; 85(6):1221-6.